Layer 1

NMS eligibility criteria to be expanded following child asthma enquiry

The pharmacist could not flag uncollected prescribed asthma medicines on the SCR

NHSE&I is widening the eligibility criteria for the NMS to allow guardians to provide consent on a patient's behalf, following an enquiry into the management of chronic asthma.

The Healthcare Safety Investigation Branch (HSIB) – an independent investigatory body funded by the Department of Health and Social Care (DH) – published a report today (May 5), listing its recommendations to improve the management of chronic asthma in children aged 16 or under.

The report primarily focuses on the learnings from a case of a child who experienced a “near-fatal asthma attack” when he was five.

Too young to give “informed consent” 

In the case of the five-year-old child, HSIB heard during the investigation that he was too young to “provide informed consent” and was therefore not eligible for medicines use reviews (MURs) or the new medicines service (NMS).

Medicines adherence was an issue, in that the child was not being given the corticosteroid medication he had been prescribed “in line with the prescriber’s instructions”, according to the HSIB report.

“The community pharmacist told the investigation that had the child been eligible for an MUR, the irregularities in collecting medicines may well have been identified, with appropriate feedback provided to the prescriber,” HSIB wrote in the report.

The pharmacy was also not monitoring the child’s adherence to medication, due to “minimal information being available to it”.

“The investigation heard that if community pharmacists could edit the summary care record (SCR), they could upload information such as uncollected prescribed medicines,” according to the report.

MURs were decommissioned in April this year and replaced with structured medication reviews (SMRs), which are completed by GP or primary care network pharmacists.

The HSIB said that, following its investigation, NHS England and NHS Improvement (NHSE&I) “plans to make clarifications that children should be considered eligible for SMRs and the NMS, even if too young to consent themselves”.

NMS service specification to be amended

HSIB said that NHSE&I will amend the NMS’s service specification and accompanying guidance and toolkit “to reinforce that ‘the service can be offered to younger children involving their guardians as well as to older patients involving their carers where appropriate’”.

Pharmacists should continue to follow the latest guidance before the updates are issued, NHSE&I told C+D today.

Commenting on the HSIB report, an NHSE&I spokesperson said: “The NHS is already implementing the recommendations of the report with improved asthma care at the heart of the NHS long-term plan, which committed to improving asthma outcomes for children and young people”.

A Pharmaceutical Services Negotiating Committee spokesperson told C+D today that any change to the NMS service specification will be negotiated with NHSE&I and the DH.

*This article was updated after publication following extra information from PSNC

Pharmacy teams are aptly placed to support correct inhaler technique and to identify any issues with compliance or adherence. Read C+D’s clinical article on the importance of “going back to basics” with good inhaler technique in younger patients.

Will expanding the NMS eligibility criteria help your patients with asthma?

Interleukin -2, Community pharmacist

...The era of murs is one I personally look back on with mixed feelings. Noble in ideal but degenerated to levels akin to racketeering by the multiples with their relentless pusuit of "targets".No one service did more damage to the public brand image of pharmacists than MURs. Soon as it became a game of numbers rather than value for patients it deserved to be scrapped. Good riddance.

Tom Jerry, Community pharmacist

"MURs were decommissioned in April this year and replaced with structured medication reviews (SMRs), which are completed by GP or primary care network pharmacists."


...does that mean community funding has been diverted out of Community Pharmacy

Job of the week

Pharmacist Manager
Midlands, Cheshire & Dorset
Salary dependent upon experience